E-cadherin relates to EGFR expression and lymph node metastasis in primary breast carcinoma

British Journal of Cancer

Volumn 74, Issue 8, 1996, Pages 1237-1241

  Jones, J L ^a   Royall, J E ^a   Walker, R A ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Breast carcinoma; Cytoplasmic reactivity; E cadherin; Epidermal growth factor receptor expression; Lymph node metastasis

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; UVOMORULIN;

ARTICLE; BREAST CARCINOMA; HUMAN; HUMAN TISSUE; LYMPH NODE; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL;

EID: 0029827294     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.522     Document Type: Article

References (35)

1. BECKER K-F, ATKINSON MJ, REICH U, BECKER I, NEKARDA H, SIEWERT JR AND HOFLER H. (1994). E-Cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res., 54, 3845 - 3852.
2. BERGER MS, LOCHER GW, SAURER S, GULLICK WJ, WATERFIELD MD, GRONER B AND HYNES NE. (1988). Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. Cancer Res., 48, 1238 - 1243.
3. BERX G, CLETON-JANSEN A-M, NOLLET F, DE LEEUW JF, VAN DE VIJVER MJ, CORNELISSE C AND VAN ROY F. (1995). E-Cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J., 14,6107 - 6115.
4. BRACKE ME, CHARLIER C, BRUYNEEL EA, LABIT C, MAREEL MM AND CASTRONOVO V. (1994). Tamoxifen restores the E-Cadherin function in human breast cancer MCF 7/6 cells and suppresses their invasive phenotype. Cancer Res., 54, 4607 - 4609.
5. COMAN DR. (1947). Mechanisms of the invasiveness of cancer. Science, 105, 347 - 348.
6. D'SOUZA B AND TAYLOR-PAPADIMITRIOU J. (1994). Overexpression of ERBB2 in human mammary epithelial cells signals inhibition of transcription of the E-Cadherin gene. Proc. Natl Acad. Sci. USA, 91, 7202 - 7206.
7. ELSTON CW AND ELLIS IO. (1991). Pathological prognostic factors in breast cancer I. The value of histological grade in breast cancer: experience from a large study with long term follow up. Histopathology, 19, 403 - 410.
8. FOEKENS JA, RIO M-C, SEGUIN P, VAN PUTTEN WL, FAUQUE J, NAP, M, KILJN JG AND CHAMBON P. (1990). Prediction of relapse and survival in breast cancer patients by pS2 protein status. Cancer Res., 50, 3832 - 3837.
9. FRIXEN UH, BEHRENS J, SACHS M, EBERLE G, VOSS B, WARDA A, LOCHNER D, AND BIRCHMEIER W. (1991). E-Cadherin mediated cell - cell adhesion prevents invasiveness of human carcinoma cells. J. Cell Biol., 113, 173 - 185.
10. HARTIR, GOODE NT AND WILSON RE. (1989). Molecular aspects of the metastatic cascade. Biochim. Biophys. Acta, 989, 65 - 84.
11. HASHIMOTO M, NIWA O, NITTA Y, TAKEICHI M AND YOKORO K. (1989). Unstable expression of E-Cadherin adhesion molecules in metastatic ovarian tumour cells. Jpn. J. Cancer Res., 80, 459 - 463.
12. HINCK L, NATHKE IS, PAPKOFF J AND NELSON WJ. (1994). Dynamics of cadherin/catenin complex formation: novel protein interactions and pathways of complex assembly. J. Cell Biol., 125, 1327 - 1340.
13. HIRANO S, KIMOTO N, SHIMOYAMA Y, HIROHASHI S AND TAKEICHI M. (1992). Identification of a neural α-catenin as a key regulator of cadherin function and multicellular organisation. Cell, 70, 293 - 301.
14. HOSCHUETZKY H, ABERLE H AND KEMLER R. (1994). βcatenin mediates interaction of the cadherin catenin complex with epidermal growth factor receptor. J. Cell Biol., 127, 1375 - 1380.
15. HYNES R. (1992). Integrins: versatility, modulation and signaling in cell adhesion. Cell. 69, 11 - 25.
16. KANAI Y, ODA T, TSUDA H, OCHIAI A AND HIROHASHI S. (1994). Point mutation of the E-Cadherin gene in invasive lobular carcinoma of the breast. Jpn. J. Cancer Res., 85, 1035 - 1039.
17. KEMLER R. (1992). Classical cadherins. Semin. Cell Biol., 3, 149 - 155.
18. KEMLER R. (1993). From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion. Trends Genet., 9, 317 - 321.
19. KINSELLA AR, GREEN B, LEPTS GC, HILL CL, BOWIE G AND TAYLOR BA. (1993). The role of cell adhesion molecule E-cadherin in large bowel tumour cell invasion and metastasis. Br. J. Cancer, 67, 904 - 909.
20. LIPPONEN P, SAARELAINEN E, JL H, AALTOMAA S AND SYRJANEN K. (1994). Expression of E-cadherin (E-Cd) as related to other prognostic factors and survival in breast cancer. J. Pathol., 174, 101 - 109.
21. MAREEL MM, BEHRENS J, BIRCHMEIER W, DE BRYNE GK, VLEMINCKX K, HOOGEWIJS A, FIERS WC AND VAN ROY FM. (1991). Down regulation of E-cadherin expression in Madin Darby canine kidney (MDCK) cells inside tumours of nude mice. Int. J. Cancer, 47, 922 - 928.
22. MAYER B, JOHNSON JP, LEITL F, JAUNCH KW, HEISS MM, SCHILDBERG FW, BIRCHMEIER W AND FUNKE I. (1993). E-cadherin expression in primary and metastatic gastric cancer: down regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res., 53, 1690 - 1695.
23. MOLL R, MITZE M, FRIXEN UH, BIRCHMEIER W. (1993). Differential loss of E-cadherin in infiltrating ductal and lobular breast carcinomas. Am. J. Pathol., 143, 1731 - 1742.
24. OKA H, SHIOZAKI H, KOBAYASHI K, INOVE M, TAHARA H, KOBAYASHI T, TAKATSUKA Y, MATSUYOSHI N, HIRNO S, TAKEICHI M AND MORI T. (1993). Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res., 53, 1696-1701.
25. PIGNATELLI M, ANSARI TW, GUNTER P, LIU D, HIRANO S, TAKEICHI M, KLOPPEL G AND LEMOINE NR. (1994). Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade and advanced stage. J. Pathol., 174, 243 - 248.
26. RASBRIDGE SA, POULSOM R, MILLIS RR. (1995). In-situ hybridisation for E-cadherin in breast carcinoma. J. Pathol., 175, 142A.
27. SAINSBURY JRC, FARNDON JR, NEEDHAM GK, MALCOLM AJ AND HARRIS AL. (1987). Epidermal growth factor receptor status as a predictor of early recurrence of and death from breast cancer. Lancet, 8547, 1398 - 1402.
28. SCHIPPER JH, FRIXEN UH, BEHRENS J, UNGER A, JAHNKE K AND BIRCHMEIER W. (1991). E-cadherin expression in squamous carcinomas of head and neck: inverse correlation with tumour dedifferentiation and lymph node metastasis. Cancer Res., 51, 6328 - 6337.
29. SHIOZAKI H, KADOWAKIT, DOKI Y, INOUE M, TAMURA S, OKA H, IWAZAWA T, MATSUI S, SHIMAYA K, TAKEICHI M AND MORI T. (1995). Effect of epidermal growth factor on E-cadherin mediated adhesion in a human oesophageal cancer cell line. Br. J. Cancer, 71, 250 - 258.
30. SOMMERS CL, GELMANN EP, KEMLER R, COWIE P AND BYERS SW. (1994). Alterations in beta catenin phosphorylation and plakoglobin expression in human breast cancer cells. Cancer Res., 54, 3544 - 3552.
31. SPRINGER T. (1990). Adhesion receptors of the immune system. Nature, 346, 425 - 434.
32. TAKEICHI M. (1988). The cadherins: cell- cell adhesion molecules controlling animal morphogenesis. Development, 102, 639 - 655.
33. VLEMINCKX K, VAKAET L, MAREEL MM, FIERS W AND VAN ROY F. (1991). Genetic manipulation of E-cadherin expression by epithelial tumour cells reveals an invasion suppressor role. Cell. 66, 107 - 119.
34. WALKER RA, GULLICK W AND VARLEY JM. (1989). An evaluation of immunoreactivity for c-erbB-2 protein as a marker of short term prognosis in breast cancer. Br. J. Cancer, 60, 426-429.
35. WILLIAMS R, LALANI E-N, PIGNATELL M, PLAYFORD R AND STAMP GWH. (1995). Dispersed growth pattern of mouse mammary adenocarcinoma cell line 410.4 transfected with pS2 cDNA on 2D and 3D collagen gels. J. Pathol., 175S, 103A.